echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Notice of the 4th GenScript Cell and Gene Therapy Industry Development and Cooperation Forum

    Notice of the 4th GenScript Cell and Gene Therapy Industry Development and Cooperation Forum

    • Last Update: 2022-08-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Registration startsThe 4th GenScript Cell and Gene Therapy Industry Development and Cooperation Forum invites you to explore the road to commercialization of cell/gene therapy

    September 27, 2022 Beijing

    Official website: /gct-forum-2022.
    html

    FigureThe grand occasion of the GenScript Biotechnology Global Industry Forum held in San Francisco, USA in 2020: Chinese and
    foreign investors, entrepreneurs in the field of cell/gene therapy, and top experts including the former director of the US FDA gathered at the forum
     
     FigureThe grand occasion of GCT theme forums held in Shanghai and Nanjing in 2020 and 2021:
    Led by 9 Chinese and foreign academicians, together with industry-university-research-funded-policy experts from all walks of life, they gathered at the grand event
    Hot Topic 1: FDA Perspective - CAR-T Cell Therapy Approval Policy and Latest Regulatory Trends

    FigureDr.
    Peter Marks, director of the FDA Center for Biologics Evaluation and Research (CBER)
    Hot Topic 2: Looking at the road to profitability of innovative drugs from the perspective of GCT commercialization Hot Topic 3: How "high-priced drugs" can benefit more patients, and payment model innovation is imminent Free registration deadline is July 31.
    com/s/UbuQZjs/# event@genscript.
    com
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.